الإسهال الوظيفي: ماذا تفعل عندما لم يُحسّن اللوبراميد تكرار البراز أو قوامه

References

DOI: 10.1002/ueg2.12259

There is limited evidence of efficacy of rifaximin in the treatment of FDr.

In two identically designed, phase 3, placebo‐controlled studies, the efficacy of rifaximin, at a dose of 550 mg three times daily for 2 weeks, was assessed in determining significant relief of IBS global symptoms, bloating, abdominal pain, and loose or watery stools.

View source ↗